These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7791421)

  • 21. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group.
    Geroulanos SJ
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():191-205. PubMed ID: 8543495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of seizures among the carbapenems: a meta-analysis.
    Cannon JP; Lee TA; Clark NM; Setlak P; Grim SA
    J Antimicrob Chemother; 2014 Aug; 69(8):2043-55. PubMed ID: 24744302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
    Brink AJ; Botha RF; Poswa X; Senekal M; Badal RE; Grolman DC; Richards GA; Feldman C; Boffard KD; Veller M; Joubert I; Pretorius J
    Surg Infect (Larchmt); 2012 Feb; 13(1):43-9. PubMed ID: 22220506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tolerance and safety of carbapenems: the use of meropenem].
    Lizasoaín M; Noriega AR
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():73-7. PubMed ID: 9410074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doripenem: a new carbapenem antibiotic.
    Chahine EB; Ferrill MJ; Poulakos MN
    Am J Health Syst Pharm; 2010 Dec; 67(23):2015-24. PubMed ID: 21098373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empiric carbapenem monotherapy in pediatric bone marrow transplant recipients.
    Nelson WK; Rayback PA; Quinones R; Giller RH
    Ann Pharmacother; 2002 Sep; 36(9):1360-5. PubMed ID: 12196052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doripenem.
    Anderson DL
    Drugs Today (Barc); 2006 Jun; 42(6):399-404. PubMed ID: 16845443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is it safe to use carbapenems in patients with a history of allergy to penicillin?
    Sodhi M; Axtell SS; Callahan J; Shekar R
    J Antimicrob Chemother; 2004 Dec; 54(6):1155-7. PubMed ID: 15486083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meropenem: laboratory and clinical data.
    Drusano G
    Clin Microbiol Infect; 1997 Feb; 3 Suppl 4():S51-S59. PubMed ID: 11869241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic activity of meropenem in experimental infections.
    Edwards JR; Williams S; Nairn K
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():279-85. PubMed ID: 2681126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology of carbapenems in neonates.
    Pacifici GM; Allegaert K
    J Chemother; 2014 Apr; 26(2):67-73. PubMed ID: 24090536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The carbapenems: new broad spectrum beta-lactam antibiotics.
    Moellering RC; Eliopoulos GM; Sentochnik DE
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():1-7. PubMed ID: 2681123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():109-16. PubMed ID: 23835967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility testing of Stenotrophomonas maltophilia to carbapenems.
    Howe RA; Wilson MP; Walsh TR; Millar MR
    J Antimicrob Chemother; 1997 Jul; 40(1):13-7. PubMed ID: 9249199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial resistance to carbapenems.
    Livermore DM
    Adv Exp Med Biol; 1995; 390():25-47. PubMed ID: 8718600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory data which differentiate meropenem and imipenem.
    Edwards JR; Turner PJ
    Scand J Infect Dis Suppl; 1995; 96():5-10. PubMed ID: 7652504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections.
    Chang DC; Wilson SE
    Am J Surg; 1997 Sep; 174(3):284-90. PubMed ID: 9324138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.